BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33428441
Number of visits today
10170
Number of downloads
16619255
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Díaz Del Campo LS, Rodrigues-Díez R, Salaices M, Briones AM, García-Redondo AB. Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling. Int J Mol Sci 2022;23:3592. [PMID: 35408952 DOI: 10.3390/ijms23073592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yasmeen N, Selvaraj H, Lakhawat SS, Datta M, Sharma PK, Jain A, Khanna R, Srinivasan J, Kumar V. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators. Biochem Pharmacol 2023;209:115437. [PMID: 36731803 DOI: 10.1016/j.bcp.2023.115437] [Reference Citation Analysis]
2 Díaz Del Campo LS, García-Redondo AB, Rodríguez C, Zaragoza C, Duro-Sánchez S, Palmas F, de Benito-Bueno A, Socuéllamos PG, Peraza DA, Rodrigues-Díez R, Valenzuela C, Dalli J, Salaices M, Briones AM. Resolvin D2 Attenuates Cardiovascular Damage in Angiotensin II-Induced Hypertension. Hypertension 2023;80:84-96. [PMID: 36337053 DOI: 10.1161/HYPERTENSIONAHA.122.19448] [Reference Citation Analysis]
3 Anand S, Azam Ansari M, Kumaraswamy Sukrutha S, Alomary MN, Anwar Khan A, Elderdery AY. Resolvins Lipid Mediators: Potential Therapeutic Targets in Alzheimer and Parkinson Disease. Neuroscience 2022;507:139-48. [PMID: 36372297 DOI: 10.1016/j.neuroscience.2022.11.001] [Reference Citation Analysis]
4 Yamaguchi A, Botta E, Holinstat M. Eicosanoids in inflammation in the blood and the vessel. Front Pharmacol 2022;13:997403. [PMID: 36238558 DOI: 10.3389/fphar.2022.997403] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liotti F, Marotta M, Melillo RM, Prevete N. The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression. Cancers 2022;14:3333. [DOI: 10.3390/cancers14143333] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345